本页面由Tiger Fintech (Singapore) Pte. Ltd.提供服务

Olema Pharmaceuticals, Inc.

5.62
+0.33006.24%
盘后5.620.00000.00%18:43 EDT
成交量:98.32万
成交额:551.44万
市值:3.84亿
市盈率:-2.55
高:5.74
开:5.35
低:5.33
收:5.29
数据加载中...
2024/01/08

重要事件披露

Form 8-K - Current report
2024/01/08

重要事件披露

Form 8-K - Current report
2024/01/06

重要事件披露

Form 8-K - Current report
2023/12/29

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2023/12/06

重要事件披露

Form 8-K - Current report
2023/12/06

重要事件披露

Form 8-K - Current report
2023/11/30

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2023/11/28

超过5%披露

Form SC 13D/A - General statement of acquisition of beneficial ownership: [Amend]
2023/11/23

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2023/11/23

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2023/11/23

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2023/11/23

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2023/11/23

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2023/11/22

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2023/11/22

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2023/11/22

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2023/11/22

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2023/11/22

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2023/11/09

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2023/11/08

季度报告

Form 10-Q - Quarterly report [Sections 13 or 15(d)]